Victor Nizet Selected Research

Nafcillin

12/2017	Synergy between Ursolic and Oleanolic Acids from Vitellaria paradoxa Leaf Extract and β-Lactams against Methicillin-Resistant Staphylococcus aureus: In Vitro and In Vivo Activity and Underlying Mechanisms.
2/2014	Nafcillin enhances innate immune-mediated killing of methicillin-resistant Staphylococcus aureus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Victor Nizet Research Topics

Disease

147	Infections 05/2022 - 01/2002
30	Inflammation (Inflammations) 11/2021 - 08/2003
21	Bacteremia 05/2022 - 07/2011
21	Bacterial Infections (Bacterial Infection) 12/2020 - 01/2003
18	Sepsis (Septicemia) 10/2021 - 06/2002
18	Hypoxia (Hypoxemia) 04/2015 - 03/2003
11	Communicable Diseases (Infectious Diseases) 01/2019 - 01/2006
9	Pneumonia (Pneumonitis) 01/2022 - 09/2011
7	Anthrax 01/2018 - 06/2008
7	Meningitis 11/2017 - 09/2003
5	Endocarditis 05/2022 - 02/2012
5	Neoplasms (Cancer) 12/2020 - 01/2013
5	Septic Shock (Toxic Shock Syndrome) 01/2019 - 11/2002
5	Necrotizing Fasciitis 01/2018 - 02/2006
4	Pharyngitis (Sore Throat) 12/2020 - 09/2011
4	Streptococcal Infections (Streptococcal Infection) 06/2020 - 08/2007
4	Lung Injury 01/2018 - 03/2010
4	Muscle Cramp (Cramp) 01/2018 - 08/2009
3	Thrombocytopenia (Thrombopenia) 11/2021 - 06/2008
3	Disease Progression 11/2021 - 07/2007
3	Weight Loss (Weight Reduction) 12/2020 - 02/2011
3	Tonsillitis 12/2020 - 01/2019
3	Cystic Fibrosis (Mucoviscidosis) 10/2020 - 01/2017
3	Arterial calcification of infancy 10/2018 - 06/2014
3	Hemolysis 01/2018 - 12/2002
3	Abscess 07/2016 - 07/2005
3	Anemia 12/2014 - 07/2007
3	Wounds and Injuries (Trauma) 03/2014 - 04/2007
2	Chronic Disease (Chronic Diseases) 01/2021 - 02/2006

Drug/Important Bio-Agent (IBA)

34	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 06/2002
21	CathelicidinsIBA 01/2020 - 01/2003
20	Proteins (Proteins, Gene)FDA Link 10/2021 - 01/2004
17	Virulence Factors (Pathogenicity Factors)IBA 10/2020 - 01/2002
15	CytokinesIBA 01/2019 - 06/2007
14	Antimicrobial PeptidesIBA 01/2020 - 01/2003
12	Transcription Factors (Transcription Factor)IBA 01/2021 - 03/2003
9	Peptide Hydrolases (Proteases)FDA Link 10/2020 - 02/2004
9	Daptomycin FDA Link 11/2019 - 07/2011
8	Pharmaceutical PreparationsIBA 01/2019 - 10/2010
8	Hemolysin Proteins (Hemolysins)IBA 01/2019 - 06/2002
7	Vancomycin FDA LinkGeneric 09/2021 - 05/2010
6	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 11/2009
6	Interleukin-10 (Interleukin 10)IBA 10/2020 - 01/2012
6	Sialic Acid Binding Immunoglobulin-like LectinsIBA 06/2020 - 09/2011
6	Peptides (Polypeptides)IBA 01/2018 - 09/2003
6	Oxygen (Dioxygen)IBA 04/2015 - 12/2007
5	Methicillin (Metin)FDA Link 05/2022 - 01/2013
5	InflammasomesIBA 11/2021 - 01/2015
5	ChemokinesIBA 12/2020 - 02/2004
5	Ceftaroline FDA Link 11/2019 - 08/2013
5	PerforinIBA 01/2019 - 09/2003
5	Interleukin-8 (Interleukin 8)IBA 01/2019 - 09/2003
5	Antimicrobial Cationic PeptidesIBA 11/2015 - 11/2006
5	IronIBA 01/2013 - 05/2006
4	Interleukin-6 (Interleukin 6)IBA 01/2021 - 09/2003
4	Neuraminidase (Sialidase)IBA 01/2021 - 06/2008
4	VaccinesIBA 12/2020 - 03/2010
4	Deoxyribonucleases (DNase)FDA Link 10/2020 - 02/2006
4	Ampicillin (Omnipen)FDA LinkGeneric 01/2019 - 02/2012
4	LactamsIBA 01/2019 - 07/2011
4	LipopolysaccharidesIBA 01/2019 - 06/2007
4	Therapeutic UsesIBA 01/2018 - 02/2004
4	Biological ProductsIBA 01/2018 - 01/2010
4	Phosphotransferases (Kinase)IBA 01/2018 - 06/2008
4	Pattern Recognition ReceptorsIBA 01/2018 - 02/2006
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2015 - 11/2002
4	PlasminogenIBA 01/2014 - 08/2006
3	Ertapenem (Invanz)FDA Link 05/2022 - 11/2016
3	Cefazolin (Ancef)FDA LinkGeneric 05/2022 - 11/2016
3	AntigensIBA 11/2021 - 01/2019
3	ProteomeIBA 10/2021 - 10/2019
3	Streptococcus pneumoniae plY proteinIBA 01/2021 - 02/2011
3	Adenosine Monophosphate (AMP)IBA 03/2018 - 01/2006
3	Colistin (Coly-Mycin)FDA Link 01/2018 - 07/2015
3	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2018 - 08/2003
3	AKB-4924IBA 01/2018 - 08/2013
3	LigandsIBA 01/2017 - 06/2008
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017 - 11/2010
3	ElementsIBA 01/2015 - 10/2005
3	Glycoproteins (Glycoprotein)IBA 12/2013 - 06/2008
3	NF-kappa B (NF-kB)IBA 09/2009 - 04/2005
3	HepcidinsIBA 07/2007 - 03/2005
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2007 - 08/2003
3	streptolysin SIBA 06/2007 - 01/2002
3	DefensinsIBA 11/2006 - 09/2003
3	streptococcal group B hemolysinIBA 04/2005 - 06/2002
2	beta-LactamsIBA 05/2022 - 07/2011
2	TicagrelorIBA 11/2021 - 01/2021
2	InterleukinsIBA 11/2021 - 10/2020
2	Heparitin Sulfate (Heparan Sulfate)IBA 10/2021 - 09/2015
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 06/2007
2	ExotoxinsIBA 01/2021 - 10/2020
2	Polysaccharides (Glycans)IBA 01/2021 - 02/2007
2	Complement System Proteins (Complement)IBA 01/2021 - 11/2014
2	Hypoxia-Inducible Factor 1IBA 01/2021 - 10/2007
2	Interleukin-1 (Interleukin 1)IBA 01/2021 - 06/2007
2	Metalloproteases (Metalloproteinases)IBA 10/2020 - 01/2018

Therapy/Procedure

42	Therapeutics 05/2022 - 10/2005
2	Immunotherapy 01/2021 - 01/2017
2	Salvage Therapy 12/2020 - 10/2014